Cargando…
Disease burden and vaccination priorities in Colombia
INTRODUCTION: In the context of the COVID-19 pandemic, vaccination is considered a potentially effective strategy for controlling the disease. The objective of this study is to estimate the number of people with a high risk of morbidity and those who should be prioritized in immunization planning in...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844975/ https://www.ncbi.nlm.nih.gov/pubmed/35181150 http://dx.doi.org/10.1016/j.vaccine.2022.01.014 |
_version_ | 1784651580661825536 |
---|---|
author | Quitián, Lina María Rodríguez-Martinez, Carlos E. Sossa-Briceño, Mónica P. Cortés, Jorge Alberto |
author_facet | Quitián, Lina María Rodríguez-Martinez, Carlos E. Sossa-Briceño, Mónica P. Cortés, Jorge Alberto |
author_sort | Quitián, Lina María |
collection | PubMed |
description | INTRODUCTION: In the context of the COVID-19 pandemic, vaccination is considered a potentially effective strategy for controlling the disease. The objective of this study is to estimate the number of people with a high risk of morbidity and those who should be prioritized in immunization planning in Colombia. MATERIALS AND METHODS: The population at risk by age was identified from the national census data of 2018. Various sources were identified to obtain information on the number of patients with different comorbidities, including heart failure, diabetes, chronic kidney failure, cancers, HIV infection, and obesity. Sources were also identified to estimate the number of health workers, teachers and military and police force personnel. RESULTS: By 2021, Colombia is estimated to have a total of 51,049,498 inhabitants, of whom 14% will be people over 60 years of age. Additionally, of the people with comorbidities younger than 60 years old, 5,233,241 inhabitants are expected to be obese, 592,726 are expected to have diabetes mellitus, 216,389 are expected to have chronic kidney disease, and 521,263 are expected to have heart failure, totaling 15,055,697 individuals. Combining the high-priority groups and health workers, a projected 20 million people will have mortality risk factors. CONCLUSIONS: For Colombia’s vaccination strategy to have an impact on reducing mortality, population groups with risk factors, corresponding to approximately 15 million inhabitants, as well as essential workers should be prioritized. |
format | Online Article Text |
id | pubmed-8844975 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88449752022-02-15 Disease burden and vaccination priorities in Colombia Quitián, Lina María Rodríguez-Martinez, Carlos E. Sossa-Briceño, Mónica P. Cortés, Jorge Alberto Vaccine Short Communication INTRODUCTION: In the context of the COVID-19 pandemic, vaccination is considered a potentially effective strategy for controlling the disease. The objective of this study is to estimate the number of people with a high risk of morbidity and those who should be prioritized in immunization planning in Colombia. MATERIALS AND METHODS: The population at risk by age was identified from the national census data of 2018. Various sources were identified to obtain information on the number of patients with different comorbidities, including heart failure, diabetes, chronic kidney failure, cancers, HIV infection, and obesity. Sources were also identified to estimate the number of health workers, teachers and military and police force personnel. RESULTS: By 2021, Colombia is estimated to have a total of 51,049,498 inhabitants, of whom 14% will be people over 60 years of age. Additionally, of the people with comorbidities younger than 60 years old, 5,233,241 inhabitants are expected to be obese, 592,726 are expected to have diabetes mellitus, 216,389 are expected to have chronic kidney disease, and 521,263 are expected to have heart failure, totaling 15,055,697 individuals. Combining the high-priority groups and health workers, a projected 20 million people will have mortality risk factors. CONCLUSIONS: For Colombia’s vaccination strategy to have an impact on reducing mortality, population groups with risk factors, corresponding to approximately 15 million inhabitants, as well as essential workers should be prioritized. Elsevier Ltd. 2022-03-15 2022-02-15 /pmc/articles/PMC8844975/ /pubmed/35181150 http://dx.doi.org/10.1016/j.vaccine.2022.01.014 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Quitián, Lina María Rodríguez-Martinez, Carlos E. Sossa-Briceño, Mónica P. Cortés, Jorge Alberto Disease burden and vaccination priorities in Colombia |
title | Disease burden and vaccination priorities in Colombia |
title_full | Disease burden and vaccination priorities in Colombia |
title_fullStr | Disease burden and vaccination priorities in Colombia |
title_full_unstemmed | Disease burden and vaccination priorities in Colombia |
title_short | Disease burden and vaccination priorities in Colombia |
title_sort | disease burden and vaccination priorities in colombia |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844975/ https://www.ncbi.nlm.nih.gov/pubmed/35181150 http://dx.doi.org/10.1016/j.vaccine.2022.01.014 |
work_keys_str_mv | AT quitianlinamaria diseaseburdenandvaccinationprioritiesincolombia AT rodriguezmartinezcarlose diseaseburdenandvaccinationprioritiesincolombia AT sossabricenomonicap diseaseburdenandvaccinationprioritiesincolombia AT cortesjorgealberto diseaseburdenandvaccinationprioritiesincolombia |